Multi-omics identifies a T2DM-associated immune-regulatory network modulated by electroacupuncture
Chuyun Chen1,2, Wengai Huang2, Lihong Lu2
1Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.
Frontiers in Endocrinology
|April 17, 2026
Summary
This study reveals immune-related genes, including LTBP3 and PLXNB2, are key in type 2 diabetes (T2DM) development. Electroacupuncture (EA) therapy effectively targets these genes, offering new insights into T2DM treatment.
Area of Science:
- Immunology
- Genetics
- Metabolic Disorders
Background:
- Emerging evidence links immune system activity to type 2 diabetes (T2DM) pathogenesis.
- Specific genes and molecular mechanisms underlying this association require further elucidation.
- Multi-omics data integration offers a powerful approach to uncover these complex relationships.
Purpose of the Study:
- To investigate the mechanistic link between immune-related genes and T2DM.
- To identify key candidate genes involved in T2DM pathogenesis using genetic and omics data.
- To validate the functional role of identified genes and explore therapeutic interventions.
Main Methods:
- Summary data-based Mendelian Randomization (SMR) and colocalization analyses were performed using immune-related quantitative trait loci (QTL) and genome-wide association study (GWAS) data.
- Key candidate genes were functionally validated in a high-fat diet-induced T2DM mouse model.
- Gene expression levels and the impact of electroacupuncture (EA) treatment were assessed using RT-qPCR.
Main Results:
- SMR and colocalization analyses identified LTBP3 and PLXNB2 as core T2DM-associated genes.
- The T2DM mouse model demonstrated altered expression of Plxnb2 and Ltbp3, alongside coordinated changes in the TGF-β pathway, indicating an immune regulatory network.
- EA intervention significantly modulated the expression of genes within this network, including Plxnb2, Ltbp3, and TGF-β.
Conclusions:
- The study highlights the critical role of immune-related genes, such as LTBP3, PLXNB2, TGF-β, and IgA, in T2DM pathogenesis.
- Findings provide direct evidence for the molecular mechanisms of EA's therapeutic effects in T2DM by demonstrating its modulation of these key genes.
- This research integrates human genetic data with in vivo validation to underscore the importance of immune pathways in T2DM.


